A single institutional experience of thymic epithelial tumours over 11 years: Clinical features and outcome and implications for future management

British Journal of Cancer

Volumn 97, Issue 1, 2007, Pages 22-28

  Lee, H S ^a,b   Kim, S T ^a   Lee, J ^a   Choi, Y S ^a   Han, J H ^a   Ahn, Y C ^a   Lee, K S ^a   Ahn, J S ^a   Ahn, M J ^a   Kim, K ^a   Shim, Y M ^a   Kim, J ^a,b   Park, K ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Masaoka's staging system; Thymic epithelial tumour (TET); WHO histologic classification

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LOG RANK TEST; LUNG; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERICARDIUM; PLEURA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THYMECTOMY; THYMOMA; TIME SERIES ANALYSIS; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMECTOMY; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 34347363141     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603833     Document Type: Article

References (29)

1. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, Ginsberg RJ, Martini N, McCormack PM, Rusch V, Burt ME (1995) Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60: 908-913. discussion 914
2. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F (2002) Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumours. Am J Surg Pathol 26: 1605-1611
3. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumours: a clinicopathologic study of 200 thymoma cases from China. Cancer 95: 420-429
4. Fang W, Chen W, Chen G, Jiang Y (2005) Surgical management of thymic epithelial tumours: a retrospective review of 204 cases. Ann Thorac Surg 80: 2002-2007
5. Hsu CP, Chen CY, Chen CL, Lin CT, Hsu NY, Wang JH, Wang PY (1994) Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 107: 615-620
6. Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY (2005) Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumours: a clinicopathologic study of 108 patients and literature review. Chest 127: 755-761
7. Kornfeld P, Genkins G, Papatestas AE, Horowitz SH (1978) Steroid therapy in myasthenia gravis associated with thymoma. Mt Sinai J Med 45: 106-115
8. Lardinois D, Rechsteiner R, Lang RH, Gugger M, Betticher D, von Briel C, Krueger T, Ris HB (2000) Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumours. Ann Thorac Surg 69: 1550-1555
9. Loehrer Sr PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas Jr CR, Livingston R, Johnson DH (2001) Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91: 2010-2015
10. Loehrer Sr PJ, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12: 1164-1168
11. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E (1991) Thymoma: results of 241 operated cases. Ann Thorac Surg 51: 152-156
12. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492
13. Morgenthaler TI, Brown LR, Colby TV, Harper Jr CM, Coles DT (1993) Thymoma. Mayo Clin Proc 68: 1110-1123
14. Nakagawa K, Asamura H, Matsuno Y, Suzuki K, Kondo H, Maeshima A, Miyaoka E, Tsuchiya R (2003) Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126: 1134-1140
15. Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, Monden Y, Kamashima Y (1988) Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg, 95: 1041-1047
16. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94: 624-632
17. Oshita F, Kasai T, Kurata T, Fukuda M, Yamamoto N, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N (1995) Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results. Jpn J Clin Oncol 25: 208-212
18. Pescarmona E, Rendina EA, Venuta F, D'Arcangelo E, Pagani M, Ricci C, Ruco LP, Baroni CD (1990) Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 50: 534-538
19. Quintanilla-Martinez L, Wilkins Jr EW, Choi N, Efrid J, Hug E, Harris NL (1994) Thymoma: histologic subclassification is an independent prognostic factor. Cancer 74: 606-617
20. Regnard JF, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi JF, Levasseur P (1996) Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112: 376-384
21. Rena O, Papalia E, Oliaro A, Ruffini E, Filosso P, Novero D, Maggi G, Casadio C (2007) Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg 31: 109-113
22. Rieker RJ, Hoegel J, Morresi-Hauf A, Hofmann WJ, Blaeker H, Penzel R, Otto HF (2002) Histologic classification of thymic epithelial tumours: comparison of established classification schemes. Int J Cancer 98: 900-906
23. Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, Shin HJ, Ki KH, Wimberly A, Pisters KM, Schrump D, Gregurich MA, Cox JD, Roth JA, Hong WK (1998) A multidisciplinary approach to therapy for unresectable thymoma. Ann Intern Med 129: 100-104
24. Sperling B, Marschall J, Kennedy R, Pahwa P, Chibbar R (2003) Thymoma: a review of the clinical and pathological findings in 65 cases. Can J Surg 46: 37-42
25. Sunpaweravong P, Kelly K (2004) Treatment of thymoma: a comparative study between Thailand and the United States and a review of the literature. Am J Clin Oncol 27: 236-246
26. Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: state of the art. J Clin Oncol 17: 2280-2289
27. Truong LD, Mody DR, Cagle PT, Jackson-York GL, Schwartz MR, Wheeler TM (1990) Thymic carcinoma. A clinicopathologic study of 13 cases. Am J Surg Pathol 14: 151-166
28. Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, Ventura L, Osti MF, Francioni F, Coloni GF (2003) Long-term outcome after multimodality treatment for stage III thymic tumours. Ann Thorac Surg 76: 1866-1872, discussion 1872
29. Wilkins Jr EW, Grillo HC, Scannell JG, Moncure AC, Mathisen DJ (1991) J. Maxwell Chamberlain Memorial Paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51: 888-892